NO20031371L - Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO20031371L
NO20031371L NO20031371A NO20031371A NO20031371L NO 20031371 L NO20031371 L NO 20031371L NO 20031371 A NO20031371 A NO 20031371A NO 20031371 A NO20031371 A NO 20031371A NO 20031371 L NO20031371 L NO 20031371L
Authority
NO
Norway
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
indoline compounds
Prior art date
Application number
NO20031371A
Other languages
English (en)
Other versions
NO20031371D0 (no
NO324761B1 (no
Inventor
Gilbert Lavielle
Olivier Muller
Mark Millan
Alain Gobert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20031371D0 publication Critical patent/NO20031371D0/no
Publication of NO20031371L publication Critical patent/NO20031371L/no
Publication of NO324761B1 publication Critical patent/NO324761B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Forbindelser med formel (I):. hvori: Rog Rsammen danner en benzoring eventuelt substituert med et halogenatom eller med en alkyl-, alkoksy-, cyano-, nitro-, hydroksy-, amino-, alkylamino-, dialkylamino- eller trifluormetylgruppe, og Rrepresenterer et hydrogenatom, eller Rrepresenterer et hydrogenatom, og Rog Rdanner sammen en benzoring eventuelt substituert med et halogenatom eller med en alkyl-, alkoksy-, cyano-, nitro-, hydroksy-, amino-, alkylamino-, dialkylamino- eller trifluormetyl- gruppe, og addisjonssalter derav med en farmasøytisk akseptabel syre eller base.Medikamenter.
NO20031371A 2002-03-27 2003-03-26 Nye indolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO324761B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203788A FR2837823B1 (fr) 2002-03-27 2002-03-27 Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20031371D0 NO20031371D0 (no) 2003-03-26
NO20031371L true NO20031371L (no) 2003-09-29
NO324761B1 NO324761B1 (no) 2007-12-10

Family

ID=8871507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031371A NO324761B1 (no) 2002-03-27 2003-03-26 Nye indolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (24)

Country Link
US (2) US6759421B2 (no)
EP (1) EP1348704B1 (no)
JP (1) JP3926284B2 (no)
KR (1) KR100562207B1 (no)
CN (1) CN1209359C (no)
AR (1) AR039145A1 (no)
AT (1) ATE326457T1 (no)
AU (1) AU2003203287B2 (no)
BR (1) BR0300759A (no)
CA (1) CA2423820C (no)
CY (1) CY1105509T1 (no)
DE (1) DE60305229T2 (no)
DK (1) DK1348704T3 (no)
EA (1) EA005620B1 (no)
ES (1) ES2263927T3 (no)
FR (1) FR2837823B1 (no)
HK (1) HK1057368A1 (no)
MX (1) MXPA03002532A (no)
NO (1) NO324761B1 (no)
NZ (1) NZ524958A (no)
PL (1) PL208281B1 (no)
PT (1) PT1348704E (no)
SI (1) SI1348704T1 (no)
ZA (1) ZA200302392B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101005534B1 (ko) * 2008-06-23 2011-01-04 (주)핼릭스케어 충격 흡수력이 우수한 인솔

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
WO1995029177A1 (en) * 1994-04-23 1995-11-02 Smithkline Beecham P.L.C. Tricyclic derivatives as 5ht2c and 5ht2b antagonists
US6221884B1 (en) * 1997-06-04 2001-04-24 Eli Lilly And Company Carboxamides useful as 5-HT1F agonists
FR2807754A1 (fr) * 2000-04-13 2001-10-19 Adir Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2423820A1 (fr) 2003-09-27
MXPA03002532A (es) 2004-09-06
ES2263927T3 (es) 2006-12-16
DE60305229D1 (de) 2006-06-22
JP2004035541A (ja) 2004-02-05
CN1209359C (zh) 2005-07-06
US20030199555A1 (en) 2003-10-23
KR20030078035A (ko) 2003-10-04
DK1348704T3 (da) 2006-09-25
CY1105509T1 (el) 2010-04-28
PL359357A1 (en) 2003-10-06
PT1348704E (pt) 2006-08-31
FR2837823B1 (fr) 2005-04-08
JP3926284B2 (ja) 2007-06-06
HK1057368A1 (en) 2004-04-02
EP1348704B1 (fr) 2006-05-17
FR2837823A1 (fr) 2003-10-03
BR0300759A (pt) 2004-09-14
NO20031371D0 (no) 2003-03-26
CN1446813A (zh) 2003-10-08
EA200300302A1 (ru) 2003-10-30
CA2423820C (fr) 2008-08-05
NO324761B1 (no) 2007-12-10
US6759421B2 (en) 2004-07-06
DE60305229T2 (de) 2007-05-24
NZ524958A (en) 2004-03-26
AU2003203287B2 (en) 2008-08-28
SI1348704T1 (sl) 2006-08-31
AU2003203287A1 (en) 2003-10-23
ZA200302392B (en) 2003-09-30
US7053108B2 (en) 2006-05-30
EP1348704A1 (fr) 2003-10-01
US20040192736A1 (en) 2004-09-30
KR100562207B1 (ko) 2006-03-22
EA005620B1 (ru) 2005-04-28
PL208281B1 (pl) 2011-04-29
AR039145A1 (es) 2005-02-09
ATE326457T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
NO20052710L (no) Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
DE60225671D1 (de) Pharmazeutisch wirksame piperidinderivate
AR012593A1 (es) Pirrolopiridinas sustituidas, composicion farmaceutica que las contiene, procedimiento para su preparacion y el uso de las mismas en la manufacturade un medicamento
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
WO2005095395A3 (en) Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
NO20092033L (no) Nye forbindelser
BRPI0509364B8 (pt) derivados de tetraidroquinolina, composição farmacêutica que os compreende e um processo por preparar os referidos derivados
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
HUP0202787A2 (hu) 5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CO5580770A2 (es) Compuestos de quinolina terapeuticos con propiedades antagonistas de 5-ht
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
UY29739A1 (es) Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones
AR036602A1 (es) Agonistas muscarinicos
AR027335A1 (es) Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen
NO20031371L (no) Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HUP0004704A2 (hu) Dihidrofuro[3,4-b]kinolin-1-on-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
DK0880520T3 (da) Benzo[c]quinolinderivater, deres fremstilling af anvendelse som 5-alfa-reduktaseinhibitorer
NO20083753L (no) Nye pyridinylaminoalkylen- og pyridinyloksyalkylen-syklopropanaminer, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende dem
ATE524471T1 (de) Pyrazolonaphthyridinderivat
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20050572L (no) Nye benzo[b]kromeno-naftyridin-7-on- og pyrano[2',3':7,8]kino[2,3-b]kinoksalin-7-on-forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
HUP0002288A2 (hu) 7-Oxo-2,3,7,14-tetrahidro-1H-benzo[b]pirano[3,2-h]akridin-karboxilát-származékok, eljárás a vegyületek előállítására és az azokat tartalmazó gyógyszerkészítmények
NO20045540L (no) Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees